IKT Inhibikase Therapeutics announces FDA orphan drug designation granted to ikt-001 for the treatment of pah
IKT Inhibikase Therapeutics announces FDA orphan drug designation granted to ikt-001 for the treatment of pah
Story updates
12:01:26 PM UTC
SquawkNews
IKT - Inhibikase Therapeutics Announces FDA Orphan Drug Designation Granted to IKT-001 for the Treatment of PAH
12:12:36 PM UTC
SquawkNews
Inhibikase Therapeutics...
IKT - Inhibikase Therapeutics Announces FDA Orphan Drug Designation Granted to IKT-001 for the Treatment of PAH